What does A.forall Group do?
ALTER PHARMA GROUP specializes in the development, production, and distribution of generic pharmaceuticals and over-the-counter (OTC) products. The company focuses on providing high-quality healthcare solutions to meet the needs of patients and healthcare professionals. With a commitment to innovation and sustainability, ALTER PHARMA GROUP aims to enhance accessibility to essential medicines.
- Sectors
- Holding companies
- Signals
-
Reporting lossesReporting losses € -2.03M
The company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.60The current ratio is below 1: may be insufficient to cover short-term debt.
Negative cashflowNegative cashflow € -15.92MOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -1.83MEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 126.99MStrong equity provides a buffer against setbacks.
Low riskLow risk 81.1%Good solvency (> 30%) points to long-term financial stability.
High turnoverHigh turnover € 6.94MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 13.8%Social debts stay manageable relative to personnel costs.
- Directors
- Themtis Bv, Pharma Handshake Bv, Vs Pharma Consulting Llc, +3 more
- Investments
- Medigroup 100%, A.forall Development 100%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2021
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
6.94M
|
€
5.62M
|
€
6.83M
|
€
7.00M
|
|
|
€
-1.83M
|
€
-750K
|
€
284K
|
€
-283K
|
|
|
€
-16.11M
|
€
43.55M
|
€
-2.01M
|
€
13.19M
|
|
|
€
126.99M
|
€
143.10M
|
€
99.55M
|
€
101.56M
|
|
|
81.10%
|
66.81%
|
60.48%
|
61.54%
|
|
|
€
29.60M
|
€
71.08M
|
€
65.05M
|
€
63.48M
|
|
|
€
80K
|
€
879K
|
€
177K
|
€
229K
|
|
|
6.90
|
7
|
7
|
6
|
Publications 24
All publications- Ontslagen - Benoemingen 24/11/2025
- Ontslagen - Benoemingen 06/05/2024
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Benaming 11/01/2024
- Ontslagen - Benoemingen 23/12/2022
- Diversen 29/09/2022
News
Show all- France: Riverside Invests In Medical Group And Forms Strategic Partnership With Selenium Medical Investors in Healthcare 1 month ago
- Otsuka Icu Medical Llc Issues Voluntary Nationwide Recall Of 0.9% Sodium Chloride Injection, Usp Due To A Product Mix-Up With 10 Meq Potassium Chloride Injection Yahoo Finance 2 months ago
- A.forall Announces Anda Approval For Sodium Bicarbonate For Injection, Usp Yahoo Finance 4 months ago
- A.forall Announces Anda Approval For Sodium Bicarbonate For Injection, Usp BioSpace 4 months ago
- Pe Snaps Up Pharmaceutical Commercialization Assets: 5 Deals pehub.com 10 months ago
Frequently asked questions
Answers to the most common questions about A.forall Group, based on official government data and the filed annual accounts.
What is the VAT number of A.forall Group?
The VAT number of A.forall Group is BE0684.777.042.
What is the official website of A.forall Group?
The official website of A.forall Group is https://aforallpharma.com.
How many employees work at A.forall Group?
In 2024, A.forall Group employed 6.90 full-time equivalents (FTE).
When was A.forall Group established?
A.forall Group was founded in 17-11-2017.
What is the official address of A.forall Group?
The official address of A.forall Group is Marie Curiesquare 50 Anderlecht 1070.
What is the legal form of A.forall Group?
The juridical form of A.forall Group is Public limited company (NV/SA).
What is the annual revenue of A.forall Group?
The revenue of A.forall Group for the 2024 financial year was €6,938,873.
What does A.forall Group do?
ALTER PHARMA GROUP specializes in the development, production, and distribution of generic pharmaceuticals and over-the-counter (OTC) products. The company focuses on providing high-quality healthcare solutions to meet the needs of patients and healthcare professionals. With a commitment to innovation and sustainability, ALTER PHARMA GROUP aims to enhance accessibility to essential medicines.
Is A.forall Group a reliable company?
A.forall Group is a registered Rechtspersoon with company number 0684.777.042 and can be verified through the official CBE database.
What is the credit limit of A.forall Group?
The estimated credit limit of A.forall Group is €4,838,482.
Is A.forall Group still active?
A.forall Group currently has the status "Normal situation" and is active.